Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Toxicology Letters
|
June 8, 2002
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development
Christopher K Atterwill, Mark G Wing
Alternatives to Laboratory Animals : ATLA
|
December 6, 2000
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development
C K Atterwill, M G Wing
BMJ Military Health
|
August 8, 2020
Estimating the proportion of overweight soldiers in the Australian Army by combat uniform waist size
Jason Selman, M Zevenbergen, G Wing
Neuroreport
|
April 10, 1996
CD59 expression and complement susceptibility of human neuronal cell line (NTera2)
C Agoropoulou, M G Wing, A Wood
The European Journal of Neuroscience
|
March 27, 2001
Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa B
R S Nicholas, M G Wing, A Compston
Nature Biotechnology
|
July 1, 1997
Complement recruitment using bispecific diabodies
R E Kontermann, M G Wing, G Winter
Journal of Oral Rehabilitation
|
January 1, 1987
Adaptation of eight modern dental amalgams to walls of Class I cavity preparations
A L Symons, G Wing, G H Hewitt
Journal of Oral Rehabilitation
|
January 1, 1987
Adaptation of dental amalgam to the cavosurface margin of Class I cavity preparations
A L Symons, G Wing, G H Hewitt
Immunology
|
February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate
A M Montgomery, M G Wing, P J Lachmann
Clinical and Experimental Immunology
|
November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugates
A M Montgomery, M G Wing, P J Lachmann
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Toxicology Letters
|
June 8, 2002
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development
Christopher K Atterwill, Mark G Wing
Alternatives to Laboratory Animals : ATLA
|
December 6, 2000
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development
C K Atterwill, M G Wing
BMJ Military Health
|
August 8, 2020
Estimating the proportion of overweight soldiers in the Australian Army by combat uniform waist size
Jason Selman, M Zevenbergen, G Wing
Neuroreport
|
April 10, 1996
CD59 expression and complement susceptibility of human neuronal cell line (NTera2)
C Agoropoulou, M G Wing, A Wood
The European Journal of Neuroscience
|
March 27, 2001
Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa B
R S Nicholas, M G Wing, A Compston
Nature Biotechnology
|
July 1, 1997
Complement recruitment using bispecific diabodies
R E Kontermann, M G Wing, G Winter
Journal of Oral Rehabilitation
|
January 1, 1987
Adaptation of eight modern dental amalgams to walls of Class I cavity preparations
A L Symons, G Wing, G H Hewitt
Journal of Oral Rehabilitation
|
January 1, 1987
Adaptation of dental amalgam to the cavosurface margin of Class I cavity preparations
A L Symons, G Wing, G H Hewitt
Immunology
|
February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate
A M Montgomery, M G Wing, P J Lachmann
Clinical and Experimental Immunology
|
November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugates
A M Montgomery, M G Wing, P J Lachmann
Page
of 6